Navigation Links
Amgen and Peregrine Under StockCall Scrutiny: Pharma Stocks Deal with Drug Developments and Patents
Date:2/6/2013

LONDON, February 6, 2013 /PRNewswire/ --

Pharma stocks performed fairly well lately. However, the main concern for all the major companies was related to the patent expiry of their blockbuster drugs. Amgen Inc. (NASDAQ: AMGN) is about to lose its patent exclusivity for its cancer drug Neupogen. However, the sector is also witnessing good merger and acquisition activities, where big players are acquiring smaller companies in order to make up the losses sustained through patent expirations. Smaller biotech companies are also betting big on developing drugs for various cancers, though the prospects do not look so bright. StockCall analysts have released their latest round of technical research on Amgen and Peregrine. This free research can be accessed by signing up now at

http://www.stockcall.com/registration

Amgen Provides Optimistic Projections

Amgen recently reported positive results for the fourth quarter. Its revenue grew 11.25 percent to $4.42 billion while its adjusted net income stood at $1.40 per share, beating consensus estimate of $1.39 per share in quarterly net income. Amgen expects its FY 2013 adjusted earnings to be in the range of $6.85 and $7.15 per share, while revenue is likely to be in the range of $17.8 billion and $18.2 billion, in comparison to $17.3 billion in revenue it earned for FY2012. Thus, while the company is likely to report better results, but the rate of growth is likely to be a little muted. However, Amgen surpassed consensus estimates for the projections. Register today and read our free technical report on Amgen at

http://www.StockCall.com/AMGN020613.pdf

The company also successfully conducted phase 3 of its cancer drug Neulasta. Amgen draws a big chunk
'/>"/>

SOURCE StockCall.com
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Amgen to Acquire Mustafa Nevzat, a Leading Privately Held Turkish Pharmaceutical Company
2. Four Californians Selected As Breakaway from Cancer® Champions To Be Honored During Amgen Tour of California
3. Amgen to Present at the Baird Growth Stock Conference
4. Amgen To Provide Testimony At FDA Stakeholder Hearing On Biosimilars
5. Amgens BiTE® Antibody Blinatumomab (AMG 103) Achieved High Rate of Complete Response in Adult Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia
6. Amgen Announces Top-Line Results Of Phase 3 Sensipar®/Mimpara® EVOLVE™ Trial
7. Amgen Completes Acquisition of Mustafa Nevzat Pharmaceuticals
8. Amgen Completes Acquisition of KAI Pharmaceuticals
9. Amgens Second Quarter 2012 Revenues Increased 13 Percent To $4.5 Billion And Adjusted Earnings Per Share (EPS) Increased 34 Percent To $1.83
10. Amgen Announces Termination Of Ganitumab Phase 3 Study For Futility In Metastatic Pancreatic Cancer
11. Amgen To Present At The Baird Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/6/2015)... ALPHARETTA, Ga. , July 6, 2015  EndoChoice ... release its second quarter 2015 financial results on Thursday, ... EndoChoice will hold a conference call on Thursday, ... the results. The dial-in numbers are (866) 807-9684 for ... live webcast of the conference call will be available ...
(Date:7/6/2015)... July 6, 2015  OrthoSpace Ltd. ("OrthoSpace" or ... three patients in its US Investigational Device Exemption ... patient randomized, single blinded control study that compares ... repair or partial repair for the treatment of ... is currently commercially available outside of ...
(Date:7/6/2015)... , July 6, 2015 /CNW/ - The Canadian Pharmacists ... national immunization strategy to ensure that all Canadians have ... of HPV (human papillomavirus) through immunization. The lack of ... Canada is needlessly putting the ... diseases, such as HPV, continue to pose a significant ...
Breaking Medicine Technology:EndoChoice to Report Second Quarter 2015 Financial Results on August 6, 2015 2OrthoSpace Enrolls First Patients in US IDE Study 2CPhA Calls for HPV Strategy for Young Men to Save Lives 2
... 2011  Generex Biotechnology Corporation (OTCBB: GNBT.OB) today announced ... Express breast cancer vaccine did not air yesterday ... December 16, 2011 promotional spot).  The Company will ... Television advise as to a rescheduled air date ...
... 2011 The in Thought™ research ... leading provider of scientific information and analytics, today ... cardiology pipeline that gives cardiologists and their patients ... in Thought,s Leon Henderson, "Innovative Medicine Shaping ...
Cached Medicine Technology:Generex Provides Update on Bloomberg TV Breast Cancer Vaccine Segment 2Generex Provides Update on Bloomberg TV Breast Cancer Vaccine Segment 3inThought Report Says New Wave of Cardiology Drugs to Be Big Boon 2inThought Report Says New Wave of Cardiology Drugs to Be Big Boon 3inThought Report Says New Wave of Cardiology Drugs to Be Big Boon 4
(Date:7/6/2015)... CA (PRWEB) , ... July 06, 2015 , ... For ... finding medical providers for personal injury victims. Throughout the company’s history the goal ... deliver the care victims need in their recovery. And while Doctors on Liens ...
(Date:7/6/2015)... ... July 06, 2015 , ... Respected southern California personal injury attorney Fernando ... him as an attorney who has sharp legal skills as well as a superior ... for 2015 from Martindale-Hubbell and a Top 10 Award from The National Academy of ...
(Date:7/6/2015)... ... , ... University of Pittsburgh Cancer Institute (UPCI) scientists recently led ... newly available tests that better incorporate personalized medicine into diagnosing the condition. , ... is published in the July issue of the scientific journal Thyroid . ...
(Date:7/6/2015)... CA (PRWEB) , ... July 06, 2015 , ... Shortly ... on Liens , the leading network of doctors working on a lien basis. ... Doctors on Liens. , The daughter of two Cambodian refugees, Dr. Lim suffered with ...
(Date:7/6/2015)... Beach, Virginia (PRWEB) , ... July 06, 2015 ... ... States choose fat-reduction procedures each year for aesthetic reasons, which is why liposuction ... country. For a particular demographic, however, fat reduction has become more than a ...
Breaking Medicine News(10 mins):Health News:Doctors on Liens Adds Transportation to Its Ever-Expanding Network 2Health News:Doctors on Liens Adds Transportation to Its Ever-Expanding Network 3Health News:Fernando D. Vargas Awarded Top Honors in Personal Injury Law for 2015 from Two Respected Independent Organizations 2Health News:Fernando D. Vargas Awarded Top Honors in Personal Injury Law for 2015 from Two Respected Independent Organizations 3Health News:Pitt Scientists Lead Consensus Guidelines for Thyroid Cancer Molecular Tests 2Health News:Pitt Scientists Lead Consensus Guidelines for Thyroid Cancer Molecular Tests 3Health News:Pitt Scientists Lead Consensus Guidelines for Thyroid Cancer Molecular Tests 4Health News:Pitt Scientists Lead Consensus Guidelines for Thyroid Cancer Molecular Tests 5Health News:Respected Chiropractor Opens Office in Signal Hill/Cambodia Town and Joins Doctors on Liens 2Health News:Learn How CoolSculpting® and Liposuction in Virginia Beach Help Military Members Stay the Course 2Health News:Learn How CoolSculpting® and Liposuction in Virginia Beach Help Military Members Stay the Course 3
... FAIRFAX, Va., Oct. 24 Kathleen M. Foley, ... City, and Perry Fine,MD, of the University of ... in Education and Leadership Award for 2007 at ... The award recognizes,contributors to the advancement of palliative ...
... improved efficacy and reduced toxicity, studies find, , , WEDNESDAY, ... chemotherapy drug, docetaxel, to the standard two-drug regimen used ... the treatment while reducing the toxicity, two new studies ... effective that it increased survival in both studies and ...
... Norway October 24, 2007 - The use of ... increased incidence of reproductive endocrine disorders in both men ... the effects of withdrawal from two common AEDs, carbamazepine ... and female AED users. , The study finds ...
... New research results from the University at Buffalos Research ... aware of and accurately evaluate the extent of their ... use., Researchers also found that in cases where parents ... twice as likely to underestimate frequency of marijuana use ...
... by needles, experts say , , WEDNESDAY, Oct. 24 (HealthDay ... can be given the nasal spray influenza vaccine FluMist, ... only recommended for healthy people ages 5 to 49. ... than 5, but the advisers said Wednesday that FluMist ...
... to Leverage Zagat,s, Expertise to Survey Physicians; WellPoint Members ... Rate Experiences Using Zagat,s Renowned 30-Point ... WellPoint, Inc., the,nation,s largest health benefits company, and Zagat ... online survey tool that will allow,consumers to share their ...
Cached Medicine News:Health News:Two Physicians Recognized for Work in Pain and Symptom Management 2Health News:Three Chemo Drugs Better Than Two for Advanced Head/Neck Cancers 2Health News:Three Chemo Drugs Better Than Two for Advanced Head/Neck Cancers 3Health News:Gauging parent knowledge about teens' substance use 2Health News:Gauging parent knowledge about teens' substance use 3Health News:U.S. Advisers OK Nasal Spray Flu Vaccine for Young Children 2Health News:U.S. Advisers OK Nasal Spray Flu Vaccine for Young Children 3Health News:WellPoint Taps Zagat Survey to Help Consumers Rate Experiences with Their Doctors 2Health News:WellPoint Taps Zagat Survey to Help Consumers Rate Experiences with Their Doctors 3
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: